Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises.
Garmpis N, Damaskos C, Garmpi A, Kalampokas E, Kalampokas T, Spartalis E, Daskalopoulou A, Valsami S, Kontos M, Nonni A, Kontzoglou K, Perrea D, Nikiteas N, Dimitroulis D.
Garmpis N, et al. Among authors: spartalis e.
Cancer Genomics Proteomics. 2017 Sep-Oct;14(5):299-313. doi: 10.21873/cgp.20041.
Cancer Genomics Proteomics. 2017.
PMID: 28870998
Free PMC article.
Review.